Atrial High Rate Episodes Detected by Pacemaker Diagnostics Predict Death and Stroke: Report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST)

By T. Glotzer, A. Hellkamp, J. Zimmerman, M. Sweeney, R. Yee, R. Marinchak, James R. Cook, A. Paraschos, J. Love, G. Radoslovich and 2 more. Circulation, 2003

751 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine

View Paper: https://www.semanticscholar.org/paper/351ba4b92a363dbc2c6e06a0623114607402494f

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. Stanley Nattel
2. Gerhard Hindricks

Citations in the corpus

• 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation (2017, methodology): “Implantable pacemakers or defibrillators with atrial leads allow the burden of AF to be assessed by tracking the number and duration of mode switch episodes, particularly when an arrhythmia duration of >_5 minutes is used as the cutoff value.(1394) More recently, a long-term subcutaneous implantable”
• Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. (2014, background): “3% in patients given warfarin compared with 1% for patients given placebo or aspirin.(414,416,417) The optimal intensity of oral anticoagulation for stroke prevention in patients with AF is an INR of 2.”